Literature DB >> 11121059

N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains.

S Santagata1, C A Gomez, C Sobacchi, F Bozzi, M Abinun, S Pasic, P Cortes, P Vezzoni, A Villa.   

Abstract

Omenn's syndrome is an autosomal recessive primary immunodeficiency characterized by variable numbers of T lymphocytes of limited clonality, hypereosinophilia, and high IgE levels with a paradoxical absence of circulating B lymphocytes. We have previously attributed this disorder to missense mutations that render the RAG1/RAG2 recombinase only partially active. Here we report seven Omenn's patients with a novel class of genetic lesions: frameshift mutations within the 5' coding region of RAG1. Interestingly, we demonstrate in transient expression experiments that these frameshift deletion alleles remain partially functional for both deletional and inversional recombination and can hence explain the partial rearrangement phenotype observed in these patients. The rearrangement activity is mediated by truncated RAG1 proteins that are generated by alternative ATG usage 3' to the frameshift deletion and that demonstrate improper cellular localization. Taken together, our results suggest a novel mechanism for the development of immunodeficiency in a subset of Omenn's syndrome patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121059      PMCID: PMC18960          DOI: 10.1073/pnas.97.26.14572

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Genetic evidence that the RAG1 protein directly participates in V(D)J recombination through substrate recognition.

Authors:  C A Roman; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

2.  Hairpin coding end opening is mediated by RAG1 and RAG2 proteins.

Authors:  E Besmer; J Mansilla-Soto; S Cassard; D J Sawchuk; G Brown; M Sadofsky; S M Lewis; M C Nussenzweig; P Cortes
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

3.  Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2.

Authors:  E Spanopoulou; P Cortes; C Shih; C M Huang; D P Silver; P Svec; D Baltimore
Journal:  Immunity       Date:  1995-12       Impact factor: 31.745

4.  RAG1 mediates signal sequence recognition and recruitment of RAG2 in V(D)J recombination.

Authors:  M J Difilippantonio; C J McMahan; Q M Eastman; E Spanopoulou; D G Schatz
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

5.  The homeodomain region of Rag-1 reveals the parallel mechanisms of bacterial and V(D)J recombination.

Authors:  E Spanopoulou; F Zaitseva; F H Wang; S Santagata; D Baltimore; G Panayotou
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

6.  Initiation of V(D)J recombination in vitro obeying the 12/23 rule.

Authors:  Q M Eastman; T M Leu; D G Schatz
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

7.  Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps.

Authors:  J F McBlane; D C van Gent; D A Ramsden; C Romeo; C A Cuomo; M Gellert; M A Oettinger
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

8.  A zinc-binding domain involved in the dimerization of RAG1.

Authors:  K K Rodgers; Z Bu; K G Fleming; D G Schatz; D M Engelman; J E Coleman
Journal:  J Mol Biol       Date:  1996-07-05       Impact factor: 5.469

9.  RAG mutations in human B cell-negative SCID.

Authors:  K Schwarz; G H Gauss; L Ludwig; U Pannicke; Z Li; D Lindner; W Friedrich; R A Seger; T E Hansen-Hagge; S Desiderio; M R Lieber; C R Bartram
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

10.  Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.

Authors:  T Yamashita; N Wu; G Kupfer; C Corless; H Joenje; M Grompe; A D D'Andrea
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

View more
  32 in total

Review 1.  The RAG proteins in V(D)J recombination: more than just a nuclease.

Authors:  M J Sadofsky
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  The RAG1 N-terminal domain is an E3 ubiquitin ligase.

Authors:  Vyacheslav Yurchenko; Zhu Xue; Moshe Sadofsky
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

3.  The C-terminal portion of RAG2 protects against transposition in vitro.

Authors:  Sheryl K Elkin; Adam G Matthews; Marjorie A Oettinger
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

4.  A purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codon.

Authors:  Carmen Oleaga-Quintas; Caroline Deswarte; Marcela Moncada-Vélez; Ayse Metin; Indumathi Krishna Rao; Saliha Kanık-Yüksek; Alejandro Nieto-Patlán; Antoine Guérin; Belgin Gülhan; Savita Murthy; Aslınur Özkaya-Parlakay; Laurent Abel; Rubén Martínez-Barricarte; Rebeca Pérez de Diego; Stéphanie Boisson-Dupuis; Xiao-Fei Kong; Jean-Laurent Casanova; Jacinta Bustamante
Journal:  Hum Mol Genet       Date:  2018-11-15       Impact factor: 6.150

5.  Mechanism of escape from nonsense-mediated mRNA decay of human beta-globin transcripts with nonsense mutations in the first exon.

Authors:  Gabriele Neu-Yilik; Beate Amthor; Niels H Gehring; Sharif Bahri; Helena Paidassi; Matthias W Hentze; Andreas E Kulozik
Journal:  RNA       Date:  2011-03-09       Impact factor: 4.942

Review 6.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

7.  A dual interaction between the DNA damage response protein MDC1 and the RAG1 subunit of the V(D)J recombinase.

Authors:  Gideon Coster; Ayala Gold; Darlene Chen; David G Schatz; Michal Goldberg
Journal:  J Biol Chem       Date:  2012-08-31       Impact factor: 5.157

8.  The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation.

Authors:  Anne Puel; Janine Reichenbach; Jacinta Bustamante; Cheng-Lung Ku; Jacqueline Feinberg; Rainer Döffinger; Marion Bonnet; Orchidée Filipe-Santos; Ludovic de Beaucoudrey; Anne Durandy; Gerd Horneff; Francesco Novelli; Volker Wahn; Asma Smahi; Alain Israel; Tim Niehues; Jean-Laurent Casanova
Journal:  Am J Hum Genet       Date:  2006-02-15       Impact factor: 11.025

9.  Autoubiquitylation of the V(D)J recombinase protein RAG1.

Authors:  Jessica M Jones; Martin Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

Review 10.  Human RAG mutations: biochemistry and clinical implications.

Authors:  Luigi D Notarangelo; Min-Sung Kim; Jolan E Walter; Yu Nee Lee
Journal:  Nat Rev Immunol       Date:  2016-03-21       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.